Crosslink Capital Inc. lifted its position in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 1.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,240,480 shares of the company’s stock after acquiring an additional 44,520 shares during the period. Cellebrite DI makes […]
Cellebrite DI (NASDAQ:CLBT – Free Report) had its price target hoisted by JPMorgan Chase & Co. from $12.00 to $14.00 in a research report sent to investors on Friday, Benzinga reports. The firm currently has an overweight rating on the stock. Several other analysts have also commented on CLBT. Needham & Company LLC raised their […]
Cellebrite DI (NASDAQ:CLBT – Free Report) had its target price upped by Needham & Company LLC from $13.50 to $14.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the stock. A number of other equities analysts also recently issued reports on CLBT. Craig […]
LeddarTech (NASDAQ:LDTC – Get Free Report) and Cellebrite DI (NASDAQ:CLBT – Get Free Report) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation. Earnings & Valuation This table compares LeddarTech […]
Crescent Park Management L.P. grew its stake in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 326,578 shares of the company’s stock after buying an additional 27,329 shares during the […]